James CCC Header Gray Genome Wheel 2017

RECENT PUBLICATIONS OF NOTE

Medical scientists at the OSUCCC – James frequently publish cancer-related articles in prestigious scientific journals. Below is a list of articles that have appeared recently in journals with an impact factor (IF) of 7.0 or above. Articles still in press are not listed. KEY: Bolded names denote OSUCCC members; + = former member.

Ratnam NM, Peterson JM, Talbert EE, Ladner KJ, Rajasekera PV, Schmidt CR, Dillhoff ME, Swanson BJ, Haverick E, Kladney RD, Williams TM, Leone GW, Wang DJ, Guttridge DC. NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development. Journal of Clinical Investigation 2017 September (Epub ahead of print). IF: 12.784  Link

Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Garcia-Donas J, Swisher EM, Floquet A, Konecny GE, McNeish IA, Scott CL, Cameron T, Maloney L, Isaacson J, Goble S, Grace C, Harding TC, Raponi M, Sun J, Lin KK, Giordano H, Ledermann JA, ARIEL3 investigators. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomized, double-blind, placebo-controlled, phase III trial. Lancet 2017 September (Epub ahead of print). IF: 47.831  Link

Mishra A, Porcu P. Expanding and expounding the genomic map of CTCL. Blood 2017;130:1389-1390. IF: 13.164  Link

Rassenti LZ, Balatti V, Ghia EM, Palamarchuk A, Tomasello L, Fadda P, Pekarsky Y, Widhopf GF 2nd, Kipps TJ, Croce CM. MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the USA 2017 September (Epub ahead of print). IF: 9.661  Link

Yarchoan M, Xing D, Luan L, Xu H, Sharma R, Popovic A, Pawlik TM, Kim AK, Zhu Q, Jaffee EM, Taube J, Anders RA. Characterization of the immune microenvironment in hepatocellular carcinoma (HCC). Clinical Cancer Research 2017 September (Epub ahead of print). IF: 9.619  Link

Li J, Wu J, Bao X, Honea N, Xie Y, Kim S, Sparreboom A, Sanai N. Quantitative and mechanistic understanding of AZD1775 penetration across human blood-brain barrier in glioblastoma patients using an IVIVE-PBPK modeling approach. Clinical Cancer Research 2017 September (Epub ahead of print). IF: 9.619  Link

Li P, Wuthrick E, Rappaport JA, Kraft C, Lin JE, Marszalowicz G, Snook AE, Zhan T, Hyslop TM, Waldman SA. GUCY2C signaling opposes the acute radiation-induced GI syndrome. Cancer Research 2017;77:5095-5106. IF: 9.122  Link

Wei H, Cui R, Bahr J, Zanesi N, Luo Z, Meng W, Liang G, Croce CM. miR-130a deregulates PTEN and stimulates tumor growth. Cancer Research 2017 September (Epub ahead of print). IF: 9.122  Link

Chatterjee M, Ben-Josef E, Robb R, Vedaie M, Seum S, Thirumoorthy K, Palanichamy K, Harbrecht M, Chakravarti A, Williams TM. Caveolae-mediated endocytosis is critical for albumin cellular uptake and response to albumin-bound chemotherapy. Cancer Research 2017 September (Epub ahead of print). IF: 9.122  Link

© 2024 The Ohio State University Comprehensive Cancer Center –
James Cancer Hospital and Solove Research Institute
460 W. 10th Ave.
Columbus, Ohio 43210

cancer.osu.edu
News & Media
Contact Us
Blog
Research & Education
Find a Clinical Trial
Referrals to Ohio State
Patient Support